Despite another beat-and-raise quarter for Palantir, the stock’s after-hours reaction was somewhat muted. Check out PLTR's ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback